Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedRevision label updated from v3.6.3 to v3.6.4. The page content and functionality remain the same for users.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedFooter revision updated from v3.6.2 to v3.6.3. This reflects a minor version update of the page rather than changes to the study details or substantive content.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page now displays the updated revision tag (v3.6.2) indicating a newer build of the page, rather than a change to study details.SummaryDifference0.0%

- Check43 days agoChange DetectedNew navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and a recruitment status label 'No longer looking for participants', along with an updated site revision tag 'Revision: v3.6.0'. The removal of the 'Intervention / Treatment' label and the older 'Revision: v3.5.5' entry indicates a UI cleanup and version update.SummaryDifference0.4%

- Check50 days agoChange DetectedThe page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating an updated site build.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.5.4 replaces the previous v3.5.3, indicating a software update behind the page. No visible content changes to the study details are indicated.SummaryDifference0.0%

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.